Lv5
826 积分 2024-11-18 加入
Zhuriheng pills improve adipose tissue dysfunction and inflammation by modulating PPARγ to stabilize atherosclerotic plaques
12天前
已完结
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
14天前
已完结
NOX2 inhibition stabilizes vulnerable plaques by enhancing macrophage efferocytosis via MertK/PI3K/AKT pathway
14天前
已完结
Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT1R/ROS/p38 MAPK/ADAM17 pathway
15天前
已完结
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
15天前
已完结
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer
15天前
已完结
UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
15天前
已完结
Potential roles for efferocytosis in glioblastoma immune evasion
15天前
已完结
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
16天前
已完结
Gilteritinib: potent targeting of FLT3 mutations in AML
16天前
已完结
皖公网安备34019202002308
